Publications

Selected Publications

 

2024

• Gadiya Y., Shetty S., Hofmann-Apitius M., Gribbon P., & Zaliani A. (2024). "Exploring SureChEMBL from a drug discovery perspective." Scientific Data, 11(1). doi:10.1038/s41597-024-03371-4
• Jalencas X., Berg H., Espeland L. O., Sreeramulu S., Kinnen F., Richter C., Georgiou C., Yadrykhinsky V., Specker E., Jaudzems K., Miletic T., Harmel R., Gribbon P., Schwalbe H., Brenk R., Jirgensons A., Zaliani A., & Mestres J. (2024). "Design, quality and validation of the EU-OPENSCREEN fragment library poised to a high-throughput screening collection." Rsc Medicinal Chemistry, 15(4). doi:10.1039/d3md00724c
• Kuzikov M., Reinshagen J., Wycisk K., Corona A., Esposito F., Malune P., Manelfi C., Iaconis D., Beccari A., Tramontano E., Nowotny M., Windshuegel B., Gribbon P., & Zaliani A. (2024). "Drug repurposing screen to identify inhibitors of the RNA polymerase (nsp12) and helicase (nsp13) from SARS-CoV-2 replication and transcription complex." Virus Research, 343. doi:10.1016/j.virusres.2024.199356

 

2023

• Schindler M., Siegerist F., Lange T., Simm S., Bach S. M., Klawitter M., Gehrig J., Gul S., & Endlich N. (2023). "A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS-Like Zebrafish Model." Journal of the American Society of Nephrology, 34(12), 1977-1990. doi:10.1681/Asn.0000000000000235

 

2022

• Chauvistré H., Shannan B., Daignault-Mill S. M., Ju R. J., Picard D., Egetemaier S., Váraljai R., Gibhardt C. S., Sechi A., Kaschani F., Keminer O., Stehbens S. J., Liu Q., Yin X. F., Jeyakumar K., Vogel F. C. E., Krepler C., Rebecca V. W., Kubat L., Lueong S. S., Forster J., Horn S., Remke M., Ehrmann M., Paschen A., Becker J. C., Helfrich I., Rauh D., Kaiser M., Gul S., Herlyn M., Bogeski I., Rodríguez-López J. N., Haass N. K., Schadendorf D., & Roesch A. (2022). "Persister state-directed transitioning and vulnerability in melanoma." Nature Communications, 13(1). doi:10.1038/s41467-022-30641-9